CD40LG and Huntington disease: We herein designed a multicenter, observational and prospective study with the following primary endpoints: (i) to confirm the predictive role of sCD40L as a biomarker of MACE in HD; and (ii) to evaluate the role of PMMA in sCD40L modulation.